Tailored strategies for radiation therapy in classical Hodgkin's lymphoma. - Wikidata - wikimedia - TriplyDB

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q34610653

about

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q34610653

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@ast

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@en

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@nl

type

label

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@ast

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@en

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@nl

prefLabel

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@ast

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@en

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@nl

P1433

Q34610653-DADFF98E-4CF7-414B-8102-108C5F519ECC

P1476

Q34610653-49163FF0-B446-419F-B405-AE0C7C57D2F6

P2093

Q34610653-D60FAB1E-CFA7-4A50-845F-AE0021329B3D

P2860

Q34610653-00118C51-6FD1-415A-BEFB-1D64860C86B7

Q34610653-0370882B-5FFE-4939-8226-A6C34D4C7034

Q34610653-04EC559D-3803-48C9-9B5D-78D5FC24DC2C

Q34610653-088521F9-092E-4E4B-BF7F-A56EBF6E705E

Q34610653-094C062E-7FFF-401C-BEC2-2ED85617C66F

Q34610653-0E2A84F1-8040-4BA6-AC9C-C9DE09291196

Q34610653-15413C50-A653-4A47-84DC-49D8F7B93547

Q34610653-15B87DB6-E5DB-41FF-8A06-8C4428AC66CE

Q34610653-165B7C8B-9D18-48F3-ABA1-C157C86633D6

Q34610653-17083AC9-A873-498C-814F-E78D437E54C0

P304

Q34610653-7BA34CEC-633E-4EB7-A0FB-CFE153784FE5

P31

Q34610653-F339E97F-BAF5-4594-8770-6123D42A218B

P356

Q34610653-9FA75D4E-6D56-4DD3-A9FC-2BBCB6F48489

P433

Q34610653-D5174031-1924-4B35-B109-EF3C5E3E7449

P478

Q34610653-BE08DD66-6E1F-4D66-B801-4B2E08EE825D

P50

Q34610653-8D5C59FD-D294-4E25-8D0B-CBC3D9E28837

P577

Q34610653-B6417236-B486-4C52-B618-8A3286A0908B

P698

Q34610653-3F8BA997-CE82-4E4D-A65C-C8B097CC6594

P921

Q34610653-2ECBA174-D522-494E-8BAF-BE205653676D

P932

Q34610653-A2AFFC00-3539-4882-8276-8B00E6573EC6

P356

J.CRITREVONC.2012.02.006

P1433

Critical Reviews in Oncology Hematology

P1476

Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

@en

P2093

Yvette L Kasamon

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519).

Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.

Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

P304

71-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CRITREVONC.2012.02.006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie A. Terezakis

P577

2012-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22463873

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4251770

http://www.w3.org/2001/XMLSchema#string